首页>投融资

CAMP4 Therapeutics

上市

CAMP4 Therapeutics Corp is a biotechnology company that develops a gene circuity platform intended to identify de-risked druggable targets and improve therapeutic predictability. The company leverages machine learning algorithms to code the discrete set of combinatorial rules used by any human cell type central to disease pathology and solve for druggable targets, enabling the medical community to control the output of any disease gene of interest.In June 2021, CAMP4 Therapeutics Corp had raised $45 million to drive the next phase of its scientific approach to expand its platform and advance multiple preclinical RNA therapies into human testing

https://www.camp4tx.com/

470180

基本信息

公司全称

CAMP4 Therapeutics Corp
类型

可编程治疗方法开发商
产业领域

药品研发/制造、医药研发/制造、生物药、生物/化学技术
公司人数

51~100人
地址

One Kendall Square Bldg 1400 West 3rd Floor CAMBRIDGE MASSACHUSETTS 02139; US; Telephone: +16176518867;
联系电话

1-617-6518867
邮箱

info@camp4tx.com
成立时间

2016-01-01

投融资

2024-10-11

上市

7500万美元

未透露
2022-07-20

B轮

1亿美元

Gaingels

Enavate Sciences
2021-06-15

未透露

4500万美元

Polaris Partners

The Kraft Group

Andreessen Horowitz

5AM Ventures

Northpond Ventures
2018-05-31

A轮

3000万美元

The Kraft Group

Andreessen Horowitz

Polaris Partners
加载更多

CAMP4 Therapeutics

基本信息

投融资

相关投融资企业